Literature DB >> 25480718

Reply to the letter to the editor: bimonthly injections of ranibizumab for age-related macular degeneration.

Tomoko Sawada1, Masahito Ohji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25480718     DOI： 10.1007/s00417-014-2878-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  2 in total

1.  Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab.

Authors:  Philipp S Muether; Manuel M Hermann; Ulrike Viebahn; Bernd Kirchhof; Sascha Fauser
Journal:  Ophthalmology       Date:  2012-08-22       Impact factor: 12.079

2.  Bimonthly injections of ranibizumab for age-related macular degeneration.

Authors:  Tomoko Sawada; Masashi Kakinoki; Xiying Wang; Hajime Kawamura; Yoshitsugu Saishin; Masahito Ohji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-05       Impact factor: 3.117
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.